We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+0.88%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$191M
AUM Growth
-$20.5M
Cap. Flow
-$12.4M
Cap. Flow %
-6.5%
Top 10 Hldgs %
8%
Holding
450
New
8
Increased
100
Reduced
215
Closed
125

Top Buys

Rank Stock Value
1
BIPC icon
Brookfield Infrastructure
BIPC
+$1.03M
2
OXLC
Oxford Lane Capital
OXLC
+$1,000K
3
ECC
Eagle Point Credit Company
ECC
+$951K
4
ORAN
Orange
ORAN
+$441K
5
SNP
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
+$424K

Top Sells

Rank Stock Value
1
DKL icon
Delek Logistics
DKL
+$2.13M
2
WES icon
Western Midstream Partners
WES
+$888K
3
CNXM
CNX Midstream Partners LP
CNXM
+$744K
4
OSB
Norbord Inc.
OSB
+$695K
5
MPC icon
Marathon Petroleum
MPC
+$594K

Sector Composition

Rank Sector Weight
1 Healthcare 32.34%
2 Real Estate 18.02%
3 Energy 12.43%
4 Materials 10.7%
5 Financials 6.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KDMN
251
DELISTED
Kadmon Holdings, Inc.
KDMN
$264K 0.14%
67,455
-9,191
-12% -$38.6K
TVRD
252
Tvardi Therapeutics
TVRD
$20.1M
$261K 0.14%
569
-78
-12% -$45.3K
BLUE
253
DELISTED
bluebird bio
BLUE
$260K 0.14%
371
-52
-12% -$40.6K
CCXI
254
DELISTED
ChemoCentryx, Inc.
CCXI
$259K 0.14%
4,732
-654
-12% -$35.2K
CTMX icon
255
CytomX Therapeutics
CTMX
$690M
$257K 0.13%
38,721
-5,285
-12% -$39.2K
KRTX
256
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$257K 0.13%
3,322
-444
-12% -$37.8K
MYOV
257
DELISTED
Myovant Sciences Ltd.
MYOV
$257K 0.13%
18,324
-2,493
-12% -$46.4K
RUBY
258
DELISTED
Rubius Therapeutics, Inc
RUBY
$255K 0.13%
50,863
-6,930
-12% -$36.7K
DTIL icon
259
Precision BioSciences
DTIL
$178M
$254K 0.13%
1,373
-188
-12% -$37.4K
EVF
260
Eaton Vance Senior Income Trust
EVF
$90.1M
$253K 0.13%
43,130
-18,943
-31% -$108K
IMGN
261
DELISTED
Immunogen Inc
IMGN
$253K 0.13%
70,213
-9,582
-12% -$38.7K
BLW icon
262
BlackRock Limited Duration Income Trust
BLW
$490M
$250K 0.13%
16,980
-6,904
-29% -$102K
TCRT icon
263
Alaunos Therapeutics
TCRT
$4.64M
$250K 0.13%
661
-90
-12% -$39.8K
ADAP
264
DELISTED
Adaptimmune Therapeutics
ADAP
$247K 0.13%
31,009
-4,232
-12% -$37K
BCRX icon
265
BioCryst Pharmaceuticals
BCRX
$2.42B
$247K 0.13%
71,844
-9,800
-12% -$42K
RLMD icon
266
Relmada Therapeutics
RLMD
$540M
$247K 0.13%
6,564
-899
-12% -$34.7K
VKTX icon
267
Viking Therapeutics
VKTX
$3.88B
$247K 0.13%
42,507
-5,813
-12% -$40K
BCEL
268
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$247K 0.13%
17,679
-2,407
-12% -$35.9K
ARDX icon
269
Ardelyx
ARDX
$1.24B
$246K 0.13%
46,775
-6,384
-12% -$38.4K
EFF
270
DELISTED
EATON VANCE FLOATING-RATE INCOME PLUS FUND
EFF
$246K 0.13%
+17,519
New +$249K
ANAB icon
271
AnaptysBio
ANAB
$1.54B
$245K 0.13%
16,632
-2,267
-12% -$40.9K
ASMB icon
272
Assembly Biosciences
ASMB
$498M
$243K 0.13%
1,230
-168
-12% -$42.3K
APRE icon
273
Aprea Therapeutics
APRE
$7.69M
$242K 0.13%
502
-70
-12% -$39.2K
RGNX icon
274
Regenxbio
RGNX
$616M
$241K 0.13%
8,759
-1,193
-12% -$38.9K
BRW
275
Saba Capital Income & Opportunities Fund
BRW
$335M
$239K 0.13%
27,053
-10,887
-29% -$95.4K
9 10
11
12 13

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q3 2020 Portfolio in Review

As of Q3 2020, Virtus ETF Advisers held 450 positions worth $191M, down 9.7% from $211M the previous quarter. Its ten largest holdings account for 8% of the portfolio.

Virtus ETF Advisers withdrew a net $12.4M in Q3 2020, closing 125 positions and reducing 215 holdings. Its most notable exit was CNX Midstream Partners LP, an estimated $744K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 34% a quarter earlier, followed by Real Estate and Energy.

Against the trend, Virtus ETF Advisers opened a new position in Oxford Lane Capital worth $1.03M.

  • Virtus ETF Advisers's largest Q3 2020 buy was Oxford Lane Capital: 46,671 shares worth $1.03M.
  • Virtus ETF Advisers added most to Brookfield Infrastructure in Q3 2020, an estimated $1.03M increase.
  • Virtus ETF Advisers's biggest Q3 2020 reduction was Delek Logistics, cutting an estimated $2.13M.
  • Virtus ETF Advisers fully exited CNX Midstream Partners LP in Q3 2020, selling an estimated $744K.
  • Virtus ETF Advisers's ten largest holdings make up 8% of its $191M portfolio in Q3 2020.
  • Virtus ETF Advisers opened 8 new positions and closed 125 in Q3 2020.
  • Virtus ETF Advisers's portfolio value fell 9.7% quarter-over-quarter to $191M.

Based on Virtus ETF Advisers's 13F filing for Q3 2020, filed 13 Nov 2020.